Filing Details

Accession Number:
0000820081-14-000040
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-10 16:06:53
Reporting Period:
2014-11-06
Filing Date:
2014-11-10
Accepted Time:
2014-11-10 16:06:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820081 Cambrex Corp CBM Pharmaceutical Preparations (2834) 222476135
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1524372 M. William Haskel One Meadowlands Plaza
East Rutherford NJ 07073
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-06 15,000 $12.46 15,000 No 4 M Direct
Common Stock Disposition 2014-11-06 500 $23.39 14,500 No 4 S Direct
Common Stock Disposition 2014-11-06 400 $23.39 14,100 No 4 S Direct
Common Stock Disposition 2014-11-06 300 $23.38 13,800 No 4 S Direct
Common Stock Disposition 2014-11-06 500 $23.37 13,300 No 4 S Direct
Common Stock Disposition 2014-11-06 200 $23.34 13,100 No 4 S Direct
Common Stock Disposition 2014-11-06 200 $23.36 12,900 No 4 S Direct
Common Stock Disposition 2014-11-06 100 $23.33 12,800 No 4 S Direct
Common Stock Disposition 2014-11-06 300 $23.32 12,500 No 4 S Direct
Common Stock Disposition 2014-11-06 195 $23.31 12,305 No 4 S Direct
Common Stock Disposition 2014-11-06 12,305 $23.30 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-11-06 15,000 $0.00 15,000 $12.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,000 2019-10-24 No 4 M Direct
Footnotes
  1. The option representing a right to purchase 30,000 shares became exercisable in four equal annual installments beginning on October 24, 2013, which was the first anniversary of the date on which the option was granted. Fifty percent of this option has become vested.